Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators

This article was originally published in PharmAsia News

Executive Summary

SEOUL - To underscore the government's crackdown on kickbacks ahead of the implementation of a new law on the topic slated to become effective in late November, South Korea's Fair Trade Commission is launching probes of several Korean pharmaceutical firms suspected of providing illicit payments to hospitals and doctors

You may also be interested in...



Korean Government Launches Strongest-ever Drive To Root Out Rebates

SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November

Korean Government Launches Strongest-ever Drive To Root Out Rebates

SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November

Korea FDA Raids Chong Kun Dang On Kickback Allegations

SEOUL - Reflecting the Korean government's bid to crack down on medical kickbacks, Korea FDA investigators, armed with a search and seizure warrant, raided the headquarters and four branches of Chong Kun Dang Pharmaceutical following allegations that the pharma is offering illegal rebates ahead of the launch of the anti-rebate law Nov. 28

Related Content

UsernamePublicRestriction

Register

AP007430

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel